SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CRIS, Curis (formerly CBMI)
CRIS 1.170+8.3%Nov 21 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thomas Stewart who wrote (209)10/6/1999 10:34:00 AM
From: WHL   of 668
 
Regarding Cathy Reese, an analyst with Avalon Research in Boca Raton, Fla.: "In a recent research report (1997), she says that Stryker will be able to generate $485 million in sales from OP-1 in the year 2000. She predicts that Creative BioMolecules could reap $$96 million, or 85 cents a share, in profits that year from OP-1 and other lines of business." If this is still possible- we should be at $10 until approval and then at $20 thereafter!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News